A staked Injective ETF from Canary Capital has entered the SEC’s 21-day public comment period right now, and this marks the first regulatory review of an institutional staking crypto ETF…
Injective (INJ) has hit a five-month high after retesting a crucial resistance level on Monday and attempting to break out from a bullish pattern. Some analysts suggested that the cryptocurrency…
Investment company Canary Capital filed an S-1 application for a staked INJ (INJ) exchange-traded fund (ETF) with the United States Securities and Exchange Commission (SEC) on Thursday.INJ is the governance,…
Canary Capital proposed a product offering exposure to the native token of the Injective blockchain as it continues its crypto ETF filing spree.The New York-based fund group’s latest ETF proposal…
In brief
Canary has filed with the SEC to debut a staked Injective ETF.
INJ is the native token of Injective, a layer-1 blockchain.
The filing is one of several requests…
Injective took a significant step forward at the Injective Summit, where it announced three game-changing developments: iBuild, a no-code platform that lets anyone build Web3 apps using simple text commands…
Reason to trust
…